Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein

Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein

US Patent 11827688 · Granted Nov 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012